Overview and Scope
The active wound care refers to a procedure to remove devitalized and necrotic tissue to promote healing. Active wound-care products include specialized dressings such as films, foams, and hydrogels that provide a physical barrier against infection. Its purpose is to debride damaged skin tissues, control infection and pain, and stimulate new tissue growth.
Sizing and Forecast
The active wound care market size has grown strongly in recent years. It will grow from $1.44 billion in 2023 to $1.55 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing incidence of chronic wounds, rise in surgical procedures, prevalence of diabetes, patient preference for non-invasive treatments, government initiatives for wound care, awareness programs on wound management, growing focus on home healthcare.
The active wound care market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to global initiatives for wound healing, increasing geriatric population, personalized medicine approaches, demand for faster healing solutions, wound care in developing countries.. Major trends in the forecast period include advanced wound dressings adoption, technological innovations in wound care products, bioactive and biodegradable materials, telemedicine and remote patient monitoring, economic considerations and cost-effective solutions.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/active-wound-care-global-market-report
Segmentation & Regional Insights
The active wound care market covered in this report is segmented –
1) By Product: Biomaterials, Skin-substitutes, Synthetic Skin-substitute, Growth Factors
2) By Indications: Burns, Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers
3) By Application: Chronic Wounds, Acute Wounds
4) By End-User: Hospitals, Clinics, Home Care Settings, Other End-users
North America was the largest region in the active wound care market in 2023. The regions covered in the active wound care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8123&type=smp
Major Driver Impacting Market Growth
The rising number of diabetic patients worldwide is expected to propel the growth of the active wound care market going forward. Obesity is a condition that arises from having excessively high blood glucose, which causes sores and ulcers, thus increasing the risk of infections and other severe complications. Through active wound care treatment, the patient gets into a healing process with a planned approach by applying various solutions and treatments to wounds, thus increasing the demand for active wound care. For instance, in December 2021, according to the report published by the IDF (International Diabetes Federation) on diabetes, there are 537 million adults (20–79 years old) living with diabetes around the world. This figure is expected to increase to 643 million by 2030 and 783 million by 2045. Furthermore, diabetes caused 6.7 million deaths in 2021. Therefore, the rising number of diabetic patients and deaths will drive the growth of the active wound care market.
Key Industry Players
Major companies operating in the active wound care market report are Smith & Nephew plc, MiMedx Group Inc., Tissue Regenix Group, Organogenesis Inc., Acell Inc., Integra Life Sciences Holdings Corporation, Solsys Medical LLC, Osiris Therapeutics Inc., Cytori Therapeutics Inc., Human BioSciences Inc., Wright Medical Group NV, Mölnlycke Health Care AB, Medline Industries Inc., AVITA Medical Inc., ConvaTec Inc., Stryker Corporation, 3M Company, Acelity L.P. Inc., B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health Inc., Celularity Inc., Coloplast A/S, Generex Biotechnology Corp., Hill-Rom Holdings Inc., Hollister Incorporated, Johnson & Johnson Inc., Lohmann & Rauscher GmbH & Co. Kg, Medtronic PLC, PAUL HARTMANN AG, Adynxx Inc., Derma sciences Inc., Baxter International Inc., Axio Biosolutions
The active wound care market report table of contents includes:
1. Executive Summary
2. Active Wound Care Market Characteristics
3. Active Wound Care Market Trends And Strategies
4. Active Wound Care Market – Macro Economic Scenario
5. Global Active Wound Care Market Size and Growth
.
.
.
26. South America Active Wound Care Market
27. Brazil Active Wound Care Market
28. Middle East Active Wound Care Market
29. Africa Active Wound Care Market
30. Active Wound Care Market Competitive Landscape And Company Profiles
Top Major Players:
- Smith & Nephew PLC
- MiMedx Group Inc
- Tissue Regenix Group
- Organogenesis Inc
- Acell Inc
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model